- Home
- RCRT vs QNRX Comparison
RCRT vs QNRX Comparison
Compare RCRT & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCRT
- QNRX
- Stock Information
- Founded
- RCRT 2010
- QNRX 2018
- Country
- RCRT United States
- QNRX United States
- Employees
- RCRT N/A
- QNRX N/A
- Industry
- RCRT EDP Services
- QNRX Medical/Dental Instruments
- Sector
- RCRT Technology
- QNRX Health Care
- Exchange
- RCRT Nasdaq
- QNRX Nasdaq
- Market Cap
- RCRT 7.0M
- QNRX 2.4M
- IPO Year
- RCRT N/A
- QNRX N/A
- Fundamental
- Price
- RCRT $2.21
- QNRX $0.77
- Analyst Decision
- RCRT
- QNRX Strong Buy
- Analyst Count
- RCRT 0
- QNRX 1
- Target Price
- RCRT N/A
- QNRX $4.00
- AVG Volume (30 Days)
- RCRT 29.5K
- QNRX 91.0K
- Earning Date
- RCRT 08-14-2024
- QNRX 11-06-2024
- Dividend Yield
- RCRT N/A
- QNRX N/A
- EPS Growth
- RCRT N/A
- QNRX N/A
- EPS
- RCRT N/A
- QNRX N/A
- Revenue
- RCRT $716,528.00
- QNRX N/A
- Revenue This Year
- RCRT $209.13
- QNRX N/A
- Revenue Next Year
- RCRT N/A
- QNRX N/A
- P/E Ratio
- RCRT N/A
- QNRX N/A
- Revenue Growth
- RCRT N/A
- QNRX N/A
- 52 Week Low
- RCRT $1.04
- QNRX $0.48
- 52 Week High
- RCRT $2.58
- QNRX $6.18
- Technical
- Relative Strength Index (RSI)
- RCRT 55.03
- QNRX 67.47
- Support Level
- RCRT $1.76
- QNRX $0.55
- Resistance Level
- RCRT $2.21
- QNRX $0.84
- Average True Range (ATR)
- RCRT 0.18
- QNRX 0.07
- MACD
- RCRT 0.00
- QNRX 0.03
- Stochastic Oscillator
- RCRT 84.91
- QNRX 79.94
About RCRT Recruiter.com Group Inc.
Recruiter.Com Group Inc is a hiring platform for the network of recruiters. It empowers businesses to recruit specialized talent faster with virtual teams of recruiters and AI job-matching technology. The Recruiter.com network of over 28,000 small and independent recruiters utilize a web platform, complete with AI-driven job matching, to recruit talent faster. Its Recruiters On Demand provides businesses of all sizes access to virtual recruiters specialized by vertical industries to source, engage, and hire talent on an as-needed basis.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.